Studientelegramm 71-2019-3/3

Titel der Studie: 2019 AHA/ACC/HRS Focused Update of the 2014 AHA/ACC/HRS Guideline for the Management of Patients With Atrial Fibrillation

Autoren: Calkins et al.

Journal: Circulation

Studientelegramm 72-2019-1/3

Titel der Studie: Cardiovascular Risk Reduction with Icosapent Ethyl for Hypertriglyceridemia

Autoren: Bhatt et al.

Journal: New England Journal of Medicine (NEJM)

Titel der Studie: Effects of Icosapent Ethyl on Total Ischemic Events: From REDUCE-IT

Autoren: Bhatt et al.

Journal: Journal of the American College of Cardiology (JACC)

Studientelegramm 71-2019-2/3

Titel der Studie: FDA adds Boxed Warning for increased risk of death with gout medicine Uloric (febuxostat)

Autoren: U.S. Food and Drug Administration (FDA)